Republicans urge Speaker Ryan to repeal device tax; AdvaMed partnering with Chinese city on device R&D;

@FierceMedDev: The top women in medical devices 2015. Feature | Follow @FierceMedDev

@VarunSaxena2: ICYMI yesterday: St. Jude earns FDA approval for recharge-free spinal cord stimulation system. Article | Follow @VarunSaxena2

@EmilyWFierce: Dx Digest: Invitae builds out cancer and epilepsy testing menus; Illumina gets in on autism research. More | Follow @EmilyWFierce

> Led by Rep. Elise Stefanik (R-NY) 44 freshman members of Congress sent a letter to new House Speaker Paul Ryan (R-WI) urging him to put a repeal of the medical device tax in a larger law by the end of the year. More

> AdvaMed signed a strategic cooperation framework agreement with the city of Xining, China, designed to promote cooperation between international med tech players and the emerging medical R&D hub, located in northwestern China. More

> Biotronik touted the results of a study of combination treatment of peripheral artery disease using its Passeo-18 Lux drug-coated balloon and Pulsar-18 self-expanding stent at the VEITH symposium in New York City. More

> Creagh Medical announced the acquisition of SurModics, a maker of percutaneous transluminal angioplasty balloon catheters. More

Biotech News

@FierceBiotech: TEDMED 2015: A brief history of CRISPR and what's next. Article | Follow @FierceBiotech

@JohnCFierce: To me, the FDA review of drisa reads like a letter to DMD parents. You don't want this drug. Please don't be angry. | Follow @JohnCFierce

@DamianFierce: "Did you name me after the mayor of New York, dad?" "Yes, Kristaps, but he was just a basketball player then." | Follow @DamianFierce

> FDA takes a dim view of BioMarin's DMD drug, citing 'contradictory' data. Story

> Samsung and Biogen verge on EU approval with an Enbrel biosimilar. Report

> AstraZeneca, Sanofi swap 210,000 compounds in no-cash deal. Article

Pharma News

@FiercePharma: Price controls loom for generic drugs in India next year. FiercePharmaAsia article | Follow @FiercePharma

@EricPFierce: ICYMI from FiercePharmaManufacturing: Baxalta Singapore plant gets FDA OK to produce Advate. Report | Follow @EricPFierce

> Horizon drops hostile takeover attack on Depomed after legal ruling. Report

> Merck KGaA rolls out big plans for expansion in Africa. Story

> Dr. Reddy's strikes back at AstraZeneca in purple pill courtroom battle. Article

Suggested Articles

Millions of tests are urgently needed as the virus keeps communities across the country in lockdown and hospitals are overwhelmed with patients.

The FDA granted its first emergency authorization for a rapid antibody blood test for COVID-19 developed by Cellex.

The ultimate goal is to move as many patients as possible out of the clinic that don’t need immediate, critical care.